Effects of C-peptide on microvascular blood flow and blood hemorheology

Experimental Diabesity Research

Volumn 5, Issue 1, 2004, Pages 51-64

  Forst, Thomas ^a   Kunt, T ^b  

^a Inst for Clinical Research/Devmt   (Germany)

^b ZMH   (United Arab Emirates)

Author keywords

C peptide; Microvascular blood flow; Nitric oxide; Sodium potassium pump; Type 1 diabetes

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); C PEPTIDE; CALCIUM; CALMODULIN; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERYL TRINITRATE; INSULIN; NITRIC OXIDE; PLACEBO; SODIUM CHLORIDE;

BLOOD RHEOLOGY; CAPILLARY FLOW; CELL FUNCTION; CELL SECRETION; CELL TYPE; CLINICAL FEATURE; DIABETES MELLITUS; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME DEFECT; ENZYME INDUCTION; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE KINETICS; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MICROANGIOPATHY; MICROVASCULARIZATION; NEUTRON DIFFRACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SKIN BLOOD FLOW; SMOOTH MUSCLE FIBER; VASODILATATION;

ANIMALS; BLOOD CIRCULATION; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HUMANS; MICROCIRCULATION; NA(+)-K(+)-EXCHANGING ATPASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RHEOLOGY;

EID: 1842690854     PISSN: 15438600     EISSN: None     Source Type: Journal    
DOI: 10.1080/15438600490424532     Document Type: Review

References (86)

1. Ahlborg, G., and Lundberg, J. M. (1996) Exercise-induced changes in neuropeptide Y, noradrenaline and endothelin-1 levels in young people with type I diabetes. Clin. Physiol., 16, 645-655.
2. Baba, Y., Kai, M., Kamada, T., Setoyama, S., and Otsuji, S. (1979) Higher levels of erythrocyte membrane microviscosity in diabetes. Diabetes, 28, 1138-1140.
3. Bareford, D., Jennings, P. E., Stone, P. C., Baar, S., Barnett, A. H., and Stuart, J. (1986) Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus. J. Clin. Pathol., 39, 722-727.
4. Barnes, A. J., Locke, O., Scudder, P. R., Dormandy, T. L., and Slack, J. (1977) Is hyperviscosity a treatable component of diabetic microcirculatory disease. Lancet, 2, 789-791.
5. Benarroch, E. E., and Low, P. A. (1991) The acetylcholine-induced flare response in evaluation of small fiber dysfunction. Ann. Neurol., 29, 590-595.
6. Boulton, A. J., Scarpello, J. H. B., and Ward, J. D. (1982) Venous oxygenation in the diabetic neuropathic foot: Evidence of arteriovenous shunting. Diabetologia, 22, 6-8.
7. Calles-Escandon, J., and Cipolla, M. (2001) Diabetes and endothelial dysfunction: A clinical perspective. Endocr. Rev., 22, 36-52.
8. Chien, S. (1987) Red cell deformability and its relevance to blood flow. Annu. Rev. Physiol., 49, 177-192.
9. Chimori, K., Miyazaki, S., Kosaka, J., Sakanaka, A., Yasuda, K., and Miura, K. (1986) Increased sodium influx into erythrocytes in diabetes mellitus and hypertension. Clin. Exp. Hypertens A, 8, 185-199.
10. Clarkson, P., Celermajer, D. S., Donald, A. E., Sampson, M., Sorensen, K. E., Adams, M., Yue, D. K., Betteridge, D. J., and Deanfield, J. E. (1996) Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J. Am. Coll. Cardiol., 28, 573-579.
11. Cohen, N. S., Ekholm, J. E., Luthra, M. G., and Hanahan, D. J. (1976) Biochemical characterization of density-separated human erythrocytes. Biochim. Biophys. Acta, 419, 229-242.
12. Cohen, R. A., and Vanhoutte, P. M. (1995) Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation, 92, 3337-3349.
13. Colwell, J. A., and Lopes-Virella, M. F. (1988) A review of the development of large-vessel disease in diabetes mellitus. Am. J. Med., 85, 113-118.
14. Corbin, D. O. C., Young, R. J., Morrison, D. C., Hoskins, P., McDicken, W. N., Housley, E., Clarke, B. F. (1987) Blood flow in the foot, polyneuropathy and foot ulceration in diabetes mellitus. Diabetologia, 30, 468-473.
15. Cotter, M. A., and Cameron, N. E. (2001) C-peptide effects on nerve conduction and blood flow in streptozotocin-induced diabetic rats: Modulation by nitric oxide synthase inhibition. Diabetes, 51(Suppl. 2), A184.
16. Danthuluri, N. R., Cybulsky, M. I., and Brock, T. A. (1988) ACh-induced calcium transients in primary cultures of rabbit aortic endothelial cells. Am. J. Physiol., 255, H1549-H1553.
17. Djemli-Shipkolye, A., Gallice, P., Coste, T., Jannot, M. F., Tsimaratos, M., Raccah, D., and Vague, P. (2000) The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients. Metabolism, 49, 868-872.
18. Dufayet, D., Raccah, D., Jannot, M. F., Coste, T., Rougerie, C., and Vague, P. (1998) Erythrocyte Na/K ATPase activity and diabetes: Relationship with C-peptide level. Diabetologia, 41, 1080-1084.
19. Elliott, T. G., Cockcroft, J. R., Groop, P. H., Viberti, G. C., and Ritter, J. M. (1993) Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: Blunted vasoconstriction in patients with microalbuminuria. Clin. Sci. (Lond.), 85, 687-693.
20. Ernst, E., and Matrai, A. (1986) Altered red and white blood cell rheology in type II diabetes. Diabetes, 35, 1412-1415.
21. Ewald, U., Tuvemo, T., and Rooth, G. (1981) Early reduction of vascular reactivity in diabetic children detected by transcutaneous oxygen electrode. Lancet, 1, 1287-1288.
22. Fernqvist-Forbes, E., Johansson, B. L., and Eriksson, M. J. (2001) Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus. Acta. Physiol. Scand., 172, 159-165.
23. +)ATPase activity in type 1 (insulin-dependent) diabetic subjects. Diabetologia, 29, 623-628.
24. Flynn, M. D., Boolell, M., Tooke, J. E, and Watkins, P. J. (1992) The effect of insulin infusion on capillary blood flow in the diabetic neuropathic foot. Diabet. Med., 9, 630-634.
25. Flynn, M. D., and Tooke, J. E. (1992) Aetilogy of diabetic foot ulceration. Diabetic Med., 8, 320-329.
26. +-ATPase activity in diabetes mellitus type I. Clin. Sci., 98, 283-290.
27. Forst, T., Kunt, T., Pohlmann, T., Goitom, K., Engelbach, M., Beyer, J., and Pfutzner, A. (1998) Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J. Clin. Invest., 101, 2036-2041.
28. Forst, T., Pfutzner, A., Bauersachs, R., Arin, M., Bach, B., Biehlmaier, H., Kustner, E., and Beyer, J. (1997) Comparison of the microvascular response to transcutaneous electrical nerve stimulation and postocclusive ischemia in the diabetic foot. J. Diabetes Complications, 11, 291-297.
29. Forstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., and Kleinert, H. (1994) Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension, 23, 1121-1131.
30. Forstermann, U., Mugge, A., Alheid, U., Haverich, A., and Frolich, J. C. (1988) Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ. Res., 62, 185-190.
31. Forstermann, U., Pollock, J. S., Schmidt, H. H., Heller, M., and Murad, F. (1991) Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U. S. A., 88, 1788-1792.
32. Forstermann, U., Warmuth, G., Dudel, C., and Alheid, U. (1989) Formation and functional importance of endothelium-derived relaxing factor (EDRF) and prostaglandins in the microcirculation. Z. Kardiol., 78 (Suppl 6), 85-91.
33. Furchgott, R. F., and Zawadzki, J. V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
34. Gardner, K., and Bennett, V. (1986) A new erythrocyte membrane-associated protein with calmodulin binding activity. Identification and purification. J. Biol. Chem., 261, 1339-1348.
35. Gawler, D., Milligan, G., Spiegel, A. M., Unson, C. G., and Houslay, M. D. (1987) Abolition of the expression of inhibitory guanine nucleotide regulatory protein Gi activity in diabetes. Nature, 327, 229-232.
36. Gerbi, A., Barbey, O., Raccah, D., Coste, T., Jamme, I., Nouvelot, L., Ouafik, L., Levy, S., Vague, P., and Maixent, J. M. (1997) Alteration of Na,K-ATPase isoenzymes in diabetic cardiomyopathy: Effect of dietary supplementation with fish oil (n-3 fatty acids) in rats. Diabetologia, 40, 496-505.
37. Greene, D. A., Lattimer, S. A., and Sima, A. A. (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med., 316, 599-606.
38. Gupta, S., McArthur, C., Grady, C., and Ruderman, N. B. (1994) Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: A cGMP-independent effect. Am. J. Physiol., 266, H2146-H2151.
39. Hach, T., Johansson, B. L., Ekberg, K., Forst, T., Kunt, T., and Wahren, J. (2002) C-peptide and its fragments increase red blood cell deformability in type 1 diabetes. Diabetes, 51, A621.
40. Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., and Fishman, M. C. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature, 377, 239-242.
41. Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W. F., DiMarchi, R. D., Di Cera, E., and Williamson, J. R. (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science, 277, 563-566.
42. Jensen, M. E., and Messina, E. J. (1999) C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin. Am. J. Physiol., 276, H1223-H1228.
43. Johansson, B. L., Linde, B., and Wahren, J. (1992) Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia, 35, 1151-1158.
44. Johansson, B. L., and Pernow, J. (1999) C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients. Acta Physiol. Scand., 165, 39-44.
45. Johnstone, M. T., Craeger, S. J., Scales, K. M., Cusco, J. A., Lee, B. A., and Craeger, M. A. (1993) Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation, 88, 2510-2516.
46. Jorneskog, G., Brismar, K., and Fagrell, B. (1995a) Skin capillary circulation is more impaired in the toes of diabetic than non-diabetic patients with peripheral vascular disease. Diabet. Med., 12, 36-41.
47. Jorneskog, G., Brismar, K., and Fagrell, B. (1995b) Skin capillary circulation severly impaired in toes of patients with IDDM, with and withourt late diabetic complications. Diabetologia, 38, 474-480.
48. Jorneskog, G., Ostergren, J., Tyden, G., Bolinder, J., and Fagrell, B. (1990) Does combined kidney and pancreas transplantation reverse functional diabetic microangiopathy? Transplant. Int., 3, 167-170.
49. Kernell, A., Ludvigsson, J., and Finnström, K. (1990) Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: Insulin antibodies and C-peptide levels. Acta Ophthalmol. Scand., 68, 415-420.
50. Kunt, T., Forst, T., Harzer, O., Buchert, G., Pfutzner, A., Lobig, M., Zschabitz, A., Stofft, E., Engelbach, M., and Beyer, J. (1998a) The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules. Exp. Clin. Endocrinol. Diabetes, 106, 183-188.
51. Kunt, T., Forst, T., Lehmann, R., Pfutzner, A., Löbig, M., Harzer, O., Engelbach, M., and Beyer, J. (1998b) Human C-peptide increases calcium influx into endothelial cells. Diabetes, 47 (Suppl 1), A30.
52. Kunt, T., Forst, T., Pfutzner, A., Beyer, J., and Wahren, J. (1998c) The physiological impact of proinsulin C-peptide. Pathophysiology, 5, 257-262.
53. Kunt, T., Schneider, S., Pfutzner, A., Goitom, K., Engelbach, M., Schauf, B., Beyer, J., and Forst, T. (1999) The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type 1 diabetes mellitus. Diabetologia, 42, 465-471.
54. Lee, T. S., MacGregor, L. C., Fluharty, S. J., and King, G. L. (1989) Differential regulation of protein kinase C and (Na,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells. J. Clin. Invest., 83, 90-94.
55. Lindstrom, K., Johansson, C., Johnsson, E., and Haraldsson, B. (1996) Acute effects of C-peptide on the microvasculature of isolated perfused skeletal muscles and kidneys in rat. Acta Physiol. Scand., 156, 19-25.
56. + transport in diabetes mellitus. Diabetes, 39, 850-854.
57. McMillan, D. E., Utterback, N. G., and LaPuma, J. (1998) Reduced erythrocyte deformability in diabetes. Diabetes, 27, 895-901.
58. McNally, P. G., Watt, P. A. C., Rimmer, T., Burden, A. C., Hearnshaw, J. R., and Thurston, H. (1994) Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin. Sci., 87, 31-36.
59. Moncada, S., and Higgs, A. (1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med., 329, 2002-2012.
60. Morris, S. J., Shore, A. C., and Tooke, J. E. (1995) Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia, 38, 1337-1344.
61. Netten, P. M., Wollersheim, H., Thien, T., and Lutterman, J. A. (1996) Skin microcirculation of the foot in diabetic neuropathy. Clin. Sci., 91, 559-565.
62. Ohtomo, Y., Aperia, A., Sahlgren, B., Johansson, B. L., and Wahren, J. (1996) C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y. Diabetologia, 39, 199-205.
63. +-ATPase activity of renal tubule segments. Diabetologia, 41, 287-291.
64. Palmer, R. M., Ferrige, A. G., and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-526.
65. Peach, M. J., Singer, H. A., Izzo, N. J., Jr., and Loeb, A. L. (1987) Role of calcium in endothelium-dependent relaxation of arterial smooth muscle. Am. J. Cardiol., 59, 35A-43A.
66. Pieper, G. M., Siebeneich, W., Moore-Hilton, G., and Roza, A. M. (1997) Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat. Diabetologia, 40, 910-915.
67. Poldermann, K. H., Stehouwer, C. D. A., vanKamp, G. J., and Gooren, L. J. G. (1996) Effects of insulin infusion on endothelium-derived vasoactive substances. Diabetologia, 39, 1284-1292.
68. Rand, V. E., and Garland, C. J. (1992) Endothelium-dependent relaxation to acetylcholine in the rabit basilar artery: Importance of membrane hyperpolarization. Br. J. Pharmacol., 106, 143-150.
69. +-pump inhibitors and membrane depolarizing agents on acetycholine-induced endothelium dependent relaxation and cyclic GMP accumulation in rat aorta. Eur. J. Pharmacol., 110, 203-209.
70. Rayman, G., Malik, R. A., Sharma, A. K., and Day, J. L. (1995) Microvascular response to tissue injury and capillary ultrastructure in the foot skin of type I diabetic patients. Clin. Sci., 89, 467-474.
71. Rigler, R., Pramanik, A., Jonasson, P., Kratz, G., Jansson, O. T., Nygren, P., Stahl, S., Ekberg, K., Johansson, B., Uhlen, S., Uhlen, M., Jornvall, H., and Wahren, J. (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc. Natl. Acad. Sci. U. S. A., 96, 13318-13323.
72. Rose, A. M., and Valdes, R., Jr. (1994) Understanding the sodium pump and its relevance to disease. Clin. Chem., 40, 1674-1685.
73. Ruggiero, D., Lecomte, M., Michoud, E., Lagarde, M., and Wiernsperger, N. (1997) Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabete Metab., 23, 30-42.
74. Sandemann, D. D., Shore, A. C., and Tooke, J. E. (1992) Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N. Engl. J. Med., 327, 760-764.
75. Schischmanoff, P. O., Winardi, R., Discher, D. E., Parra, M. K., Bicknese, S. E., Witkowska, H. E., Conboy, J. G., and Mohandas, N. (1995) Defining of the minimal domain of protein 4.1 involved in spectrin-actin binding. J. Biol. Chem., 270, 21243-21250.
76. Schmid-Schonbein, H., and Volger, E. (1976) Red-cell aggregation and red-cell deformability in diabetes. Diabetes, 25, 897-902.
77. +-ATPase activity. J Clin. Invest., 77, 503-513.
78. Sjoberg, S., Gunnarsson, R., Gjotterberg, M., Lefvert, A. K., Persson, A., and Ostman, J. (1987) Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 30, 208-213.
79. Tack, C. J., Lutterman, J. A., Vervoort, G., Thien, T., and Smits, P. (1996) Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension, 28, 426-432.
80. 2+ and calmodulin. J. Clin. Invest., 82, 394-400.
81. Tesfamariam, B., Jakubowski, J. A., and Cohen, R. A. (1989) Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2. Am. J. Physiol., 257, H1327-H1333.
82. Tooke, J. E. (1999) Microvascular function in human diabetes. A physiological perspective. Diabetes, 44, 721-726.
83. Tooke, J. E., Lins, P. E., Ostergren, J., Adamson, U., and Fagrell, B. (1985a) The effects of intravenous insulin infusion on skin microcirculatory flow in type 1 diabetes. Int. J. Microcirc. Clin. Exp., 4, 69-83.
84. Tooke, J. E., Lins, P. E., Ostergren, J., and Fagrell, B. (1985b) Skin microvascular autoregulatory responses in type I diabetes: The influence of duration and control. Int. J. Microcirc. Clin. Exp., 4, 249-256.
85. Vague, P., Dufayet, D., Coste, T., Moriscot, C., Jannot, M. F., and Raccah, D. (1997) Association of diabetic neuropathy with Na/K ATPase gene polymorphism. Diabetologia, 40, 506-511.
86. Wald, H. P., Scherzer, P., Rasch, R., and Popovtzer, M. M. (1993) Renal tubular Na,K-ATPase in diabetes mellitus: Relationship to metabolic abnormality. Am. J. Physiol., E96-E101.